Live Breaking News & Updates on Maria Fardis

Stay updated with breaking news from Maria fardis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor

FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Iovance Biotherapeutics , Maria Fardis , Frederick Vogt , Jim Ziegler , Merck Co , Risk Evaluation ,

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Brian Liu , Maria Fardis , Longwood Fund , Frazier Life Sciences , Lassen Therapeutics , Longitude Capital , Catalio Capital Management , Alta Partners , Horizon Therapeutics , Longitude Capital Managing Director Brian Liu ,

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Brian Liu , Maria Fardis , Frazier Life Sciences , Longwood Fund , Lassen Therapeutics , Longitude Capital , Catalio Capital Management , Alta Partners , Longitude Capital Managing Director Brian Liu ,

Lassen Therapeutics Presents Preclinical Data on LASN01, an Anti-IL-11 Receptor Antibody in Developm

Blockade of the IL-11 pathway with LASN01 offers a potential new therapeutic option for thyroid eye diseaseSAN DIEGO (BUSINESS WIRE) Lassen Therapeutics, a clinical stage biotechnology company developing first-in-class antibody therapeutics targeting interleukin-11 receptor (IL-11R; LASN01) as a potential treatmen. ....

District Of Columbia , United States , Maria Fardis , American Thyroid Association , Lassen Therapeutics , Annual Meeting ,